These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7766778)

  • 1. Relative incidence estimation from case series for vaccine safety evaluation.
    Farrington CP
    Biometrics; 1995 Mar; 51(1):228-35. PubMed ID: 7766778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case series analysis for censored, perturbed, or curtailed post-event exposures.
    Farrington CP; Whitaker HJ; Hocine MN
    Biostatistics; 2009 Jan; 10(1):3-16. PubMed ID: 18499654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tutorial in biostatistics: the self-controlled case series method.
    Whitaker HJ; Farrington CP; Spiessens B; Musonda P
    Stat Med; 2006 May; 25(10):1768-97. PubMed ID: 16220518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).
    Souayah N; Nasar A; Suri MF; Qureshi AI
    J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying optimal risk windows for self-controlled case series studies of vaccine safety.
    Xu S; Zhang L; Nelson JC; Zeng C; Mullooly J; McClure D; Glanz J
    Stat Med; 2011 Mar; 30(7):742-52. PubMed ID: 21394750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal detection of adverse events with imperfect confirmation rates in vaccine safety studies using self-controlled case series design.
    Xu S; Newcomer S; Nelson J; Qian L; McClure D; Pan Y; Zeng C; Glanz J
    Biom J; 2014 May; 56(3):513-25. PubMed ID: 24402780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trivalent inactivated influenza vaccine safety in children: assessing the contribution of telephone encounters.
    Mullooly JP; Crane B; Chun C
    Vaccine; 2006 Mar; 24(13):2256-63. PubMed ID: 16375995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling motor vehicle crashes using Poisson-gamma models: examining the effects of low sample mean values and small sample size on the estimation of the fixed dispersion parameter.
    Lord D
    Accid Anal Prev; 2006 Jul; 38(4):751-66. PubMed ID: 16545328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A modified self-controlled case series method to examine association between multidose vaccinations and death.
    Kuhnert R; Hecker H; Poethko-Müller C; Schlaud M; Vennemann M; Whitaker HJ; Farrington CP
    Stat Med; 2011 Mar; 30(6):666-77. PubMed ID: 21337361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of epidemiologic methods for active surveillance of vaccine safety.
    McClure DL; Glanz JM; Xu S; Hambidge SJ; Mullooly JP; Baggs J
    Vaccine; 2008 Jun; 26(26):3341-5. PubMed ID: 18462849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing data mining methods on the VAERS database.
    Banks D; Woo EJ; Burwen DR; Perucci P; Braun MM; Ball R
    Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):601-9. PubMed ID: 15954077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the distribution of a renewal process from times at which events from an independent process are detected.
    Song R; Karon JM; White E; Goldbaum G
    Biometrics; 2006 Sep; 62(3):838-46. PubMed ID: 16984327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating vaccine efficacy from household data observed over time.
    Davis XM; Haber M
    Stat Med; 2004 Oct; 23(19):2961-74. PubMed ID: 15351955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postlicensure epidemiology of childhood vaccination: the Danish experience.
    Hviid A
    Expert Rev Vaccines; 2006 Oct; 5(5):641-9. PubMed ID: 17181438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of vaccine safety after the events of 11 September 2001: role of cohort and case-control studies.
    Chen RT
    Vaccine; 2004 May; 22(15-16):2047-53. PubMed ID: 15121321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological approaches to safety investigations.
    Wood JL; Adams VJ
    Vet Microbiol; 2006 Oct; 117(1):66-70. PubMed ID: 16713135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A generalized estimating equation approach for modeling random length binary vector data.
    Albert PS; Follmann DA; Barnhart HX
    Biometrics; 1997 Sep; 53(3):1116-24. PubMed ID: 9290230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control without separate controls: evaluation of vaccine safety using case-only methods.
    Farrington CP
    Vaccine; 2004 May; 22(15-16):2064-70. PubMed ID: 15121324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Vaccine Safety Datalink project.
    DeStefano F;
    Pharmacoepidemiol Drug Saf; 2001; 10(5):403-6. PubMed ID: 11802585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.